The Role of Advanced Glycation End Products in Saphenous Vein Graft Failure
Authors:
- Alkame AkgümüşAAAlkame Akgümüş
- Bedrettin BoyrazBBBedrettin Boyraz
- Ahmet BalunABAhmet Balun
Open Access
- 9 October 2024
- journal article
- research article
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 34 (1) , 1-9
Abstract
Objective: We aimed to investigate the relationship between advanced glycation end product (AGE) levels in patients with saphenous vein graft (SVG) failure and in patients without SVG failure. Subjects and Methods: In our study, 55 patients with a history of previous coronary artery bypass grafting (CABG) surgery, who subsequently underwent coronary angiography for any reason and were found to have either SVG occlusion or significant lesions, were included as study patients. Additionally, 55 patients who have had CABG surgery without SVG failure for at least 1 year served as the control group. AGE values of the patients were measured using the skin autofluorescence method. Results: In our study results, we observed a significant difference in AGE levels between the two groups of patients with similar demographic characteristics (SVG failure groups AGE 3.2 [2.8–3.6] vs. control groups AGE 2.4 [2.1–2.7] p < 0.001). In the receiver operating characteristic curve analysis, we determined the ability of AGE levels to detect SVG failure with an area under the curve of 0.869. We found that in patients with AGE >3, it could detect SVG failure with a sensitivity of 70.9% and a specificity of 87.3%. Conclusions: Our results demonstrate that AGE levels can predict SVG failure risk inexpensively, easily, and quickly.Keywords
This publication has 30 references indexed in Scilit:
- Advanced Glycation End Products: key player of the pathogenesis of atherosclerosisGlycoconjugate Journal, 2022
- Effects of the age/rage axis in the platelet activationInternational Journal of Biological Macromolecules, 2021
- Impact of advanced glycation end products (AGEs) signaling in coronary artery diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019
- Management and Prevention of Saphenous Vein Graft Failure: A ReviewCardiology and Therapy, 2017
- Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registryCatheterization and Cardiovascular Interventions, 2016
- An update on advanced glycation endproducts and atherosclerosisBioFactors, 2012
- Coronary vein graft disease: Pathogenesis and preventionCanadian Journal of Cardiology, 2009
- Advanced glycation endproducts—role in pathology of diabetic complicationsDiabetes Research and Clinical Practice, 2005
- Advanced glycation end-products: a reviewDiabetologia, 2001
- Saphenous Vein Autograft Replacement of Severe Segmental Coronary Artery OcclusionThe Annals of Thoracic Surgery, 1968